<DOC>
	<DOCNO>NCT02807350</DOCNO>
	<brief_summary>The main objective randomize trial compare overminus lens treatment non-overminus ( spectacle without overminus spectacle plano lens ) determine : - The long-term on-treatment effect overminus treatment distance intermittent exotropia ( IXT ) control score . - The off-treatment effect overminus treatment distance IXT control score ( follow wean 3 month treatment ) .</brief_summary>
	<brief_title>Trial Overminus Spectacle Therapy Intermittent Exotropia</brief_title>
	<detailed_description>The main objective randomize trial compare overminus lens treatment non-overminus ( spectacle without overminus spectacle plano lens ) determine : - The long-term on-treatment effect overminus treatment distance IXT control score . - The off-treatment effect overminus treatment distance IXT control score ( follow wean 3 month treatment ) . The recently complete IXT3 pilot study ( NCT02223650 ) address question whether overminus lens therapy initial short-term therapeutic effect IXT wear overminus spectacle . There rigorous study address follow important question related overminus lens therapy : - Does overminus lens therapy long-term therapeutic effect IXT wear overminus spectacle ( many month year ) ? - Does overminus lens therapy long-term therapeutic effect IXT overminus spectacle discontinue ?</detailed_description>
	<mesh_term>Exotropia</mesh_term>
	<mesh_term>Mydriatics</mesh_term>
	<criteria>Age 3 year &lt; 11 year Intermittent exotropia ( manifest deviation ) meeting follow criterion : At distance : intermittent exotropia constant exotropia Mean distance control score 2 point ( mean 3 assessment exam ) At near : intermittent exotropia , exophoria , orthophoria Subject score 5 point 3 near assessment control Exodeviation least 15∆ distance measure PACT Near deviation exceed distance deviation 10∆ PACT ( convergence insufficiency type IXT exclude ) Distance visual acuity ( optotype method ) eye 0.4 logMAR ( 20/50 ) good age 3 year 0.3 logMAR ( 20/40 ) good 4 year old . Interocular difference distance visual acuity ≤0.2 logMAR ( 2 line logMAR chart ) Refractive error 6.00 diopter ( D ) standard error ( SE ) +1.00D SE ( inclusive ) myopic / least hyperopic eye base cycloplegic refraction perform within past 2 month end enrollment exam . If refractive error ( base cycloplegic refraction perform within past 2 month end enrollment exam ) meet follow criterion , prestudy spectacle require must wear least 1 week prior enrollment : SE anisometropia ≥1.00D Astigmatism ≥1.50D either eye SE myopia ≥1.00D either eye Prestudy refractive correction , worn , must meet follow criterion relative cycloplegic refraction perform within past 2 month end enrollment exam : SE anisometropia must correct within &lt; 1.00D SE anisometropic difference Astigmatism must correct within &lt; 1.00D full magnitude ; axis must within 10 degree . The SE spectacle must meet definition substantial overminus ( see exclusion criterion ) Gestational age ≥ 32 week Birth weight &gt; 1500 grams Parent understand protocol willing accept randomization overminus spectacle nonoverminus spectacle Parent home phone ( access phone ) willing contact Jaeb Center staff Investigator 's site staff Relocation outside area active PEDIG site within next 18 month anticipate Treatment IXT amblyopia ( refractive correction ) within past 4 week , include vision therapy , patching , atropine , penalization . Current contact lens wear Substantial deliberate overminus treatment within past 6 month , define spectacle overminused 1.00D SE cycloplegic refractive error ( within 2 month end enrollment exam ) Prior strabismus , intraocular , refractive surgery ( include BOTOX injection ) Abnormality cornea , lens , central retina Down syndrome cerebral palsy Severe developmental delay would interfere treatment evaluation ( opinion investigator ) . Subjects mild speech delay read and/or learn disability exclude . Any disease know affect accommodation , vergence , ocular motility multiple sclerosis , Graves orbitopathy , dysautonomia , myasthenia gravis , current use atropine amblyopia Antiseizure medication [ e.g. , carbamazepine ( Tegretol , Carbatrol , Epitol , Equetro ) , diazepam ( Valium Diastat ) , clobazam ( Frisium Onfri ) , clonazepam ( Klonopin ) , lorazepam ( Ativan ) , ethosuximide ( Zarontin ) , felbamate ( Felbatol ) , lacosamide ( VIMPAT ) , gabapentin ( Neurontin ) , oxcarbazepine ( Oxtellar XR Trileptal ) , phenobarbital , phenytoin ( Dilantin Phenytek ) , pregabalin ( Lyrica ) , tiagabine ( Gabitril ) , topiramate ( Topamax ) , valproate ( Depakote ) , zonisamide ( Zonegran ) , vigabatrin ( Sabril ) ]</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Intermittent Exotropia</keyword>
	<keyword>IXT</keyword>
	<keyword>overminus</keyword>
</DOC>